pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
IBUPROFEN AND DIPHENHYDRAMINE CITRATE
IBUPROFEN AND DIPHENHYDRAMINE CITRATE (IBUPROFEN AND DIPHENHYDRAMINE CITRATE)
DR REDDYS LABS LTD
0 catalysts
IBUPROFEN AND FAMOTIDINE
IBUPROFEN AND FAMOTIDINE (IBUPROFEN AND FAMOTIDINE)
ALKEM LABS LTD
0 catalysts
IBUPROFEN AND PSEUDOEPHEDRINE HCL
IBUPROFEN AND PSEUDOEPHEDRINE HCL (IBUPROFEN AND PSEUDOEPHEDRINE HCL)
AUROBINDO PHARMA
0 catalysts
IBUPROFEN, DIPHENHYDRAMINE HCL
IBUPROFEN, DIPHENHYDRAMINE HCL (IBUPROFEN, DIPHENHYDRAMINE HCL)
BIONPHARMA
0 catalysts
← prev
page 106 of 271
next →
131
Pain89
Neurology1
Phase 2
IC-265
Allergic Conjunctivitis
IACTA Pharmaceuticals Inc
0 catalysts
Phase 2
IC-270
Allergic Conjunctivitis
IACTA Pharmaceuticals Inc
0 catalysts
ICATIBANT
ICATIBANT (ICATIBANT)
ALEMBIC
0 catalysts
Preclinical
ICEF-16
Fecal Incontinence
Innovacell Co Ltd
0 catalysts
Phase 2
ICES-13
Stress Urinary Incontinence
Innovacell Co Ltd
0 catalysts
Phase 1
ICG-122
T-Cell Leukemia
iCell Gene Therapeutics LLC
0 catalysts
Phase 1
ICG-124
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
iCell Gene Therapeutics LLC
0 catalysts
ICOTYDE
ICOTYDE (ICOTROKINRA HYDROCHLORIDE)
Janssen Biotech Inc
0 catalysts
Phase 2
ICT-01
Metastatic Melanoma
ImCheck Therapeutics SAS
0 catalysts
Preclinical
ICT-568
Thyroid Cancer
Innovative Cellular Therapeutics Co Ltd
0 catalysts
Preclinical
ICT-6401
Autoimmune Disorders
Innovative Cellular Therapeutics Co Ltd
0 catalysts
Preclinical
ID-119040338
Parkinson's Disease
Yunovia Co Ltd
0 catalysts
Phase 1
IDE-034
Castration-Resistant Prostate Cancer (CRPC)
$IDYAIDEAYA Biosciences, Inc.
0 catalysts
Phase 2
IDE-161
Colon Cancer
$IDYAIDEAYA Biosciences, Inc.
0 catalysts
Phase 2
IDE-275
Endometrial Cancer
$IDYAIDEAYA Biosciences, Inc.
0 catalysts
Phase 2
IDE-397
Adenoid Cystic Carcinoma (ACC)
$IDYAIDEAYA Biosciences, Inc.
0 catalysts
Phase 1
IDE-574
Breast Cancer
$IDYAIDEAYA Biosciences, Inc.
0 catalysts
Phase 1
IDE-892
Esophageal Squamous Cell Carcinoma (ESCC)
$IDYAIDEAYA Biosciences, Inc.
0 catalysts
IDKIT HP ONE
IDKIT HP ONE (CITRIC ACID ANHYDROUS AND 13C UREA)
MERIDIAN BIOSCIENCE
0 catalysts
IDOSE TR
IDOSE TR (TRAVOPROST)
1 INDICATIONS AND USAGE iDose ® TR (travoprost intracameral implant) is indic…
Prostaglandin F2-alpha receptor
$GKOSGLAUKOS Corp
0 catalysts
Phase 1
IDOV-Immune
Solid Tumor
Viromissile Inc
0 catalysts
Phase 3
IFxHu-20
Merkel Cell Carcinoma
TuHURA Biosciences Inc
0 catalysts
IGALMI
IGALMI (DEXMEDETOMIDINE HYDROCHLORIDE)
1 INDICATIONS AND USAGE IGALMI is indicated for the acute treatment of agitat…
Adrenergic receptor alpha-2
$BTAIBioXcel Therapeutics, Inc.
0 catalysts
Phase 2
IGV-001
Glioblastoma Multiforme (GBM)
Imvax Inc
0 catalysts
Phase 2
IIV-HD + rC19
Coronavirus Disease 2019 (COVID-19)
$SNYSanofi
0 catalysts
Preclinical
IK-01400
Inflammatory Pain
InterK Peptide Therapeutics Ltd
0 catalysts